Health Products

ACT Methylphenidate ER (2020-02-07)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II

Summary

Product

ACT Methylphenidate ER 18 mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDIN, NPN, DIN-HIMDosage formStrength
1293319AACT Methylphenidate ER 18 mg Tablet
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
DIN 02441934Tablet (Extended-Release)Methylphenidate hydrochloride 18 mg

Reason

Affected lot(s) may be missing the desiccant.

Depth of distribution

Wholesalers, Healthcare Establishments, Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime